Back
ProShares Ultra Bloomberg Crude Oil Vs. Keros Therapeutics Industry Stock Comparison
Buy
67
UCO
ProShares Ultra Bloomberg Crude Oil
Last Price:
33.49
Seasonality Move:
-2.9%
Sell
27
KROS
Keros Therapeutics
Last Price:
45.71
Seasonality Move:
4.22%
Buy
67
ProShares Ultra Bloomberg Crude Oil (UCO)
is a Buy
Is ProShares Ultra Bloomberg Crude Oil a Buy, Sell or Hold?
- The current ProShares Ultra Bloomberg Crude Oil [UCO] share price is $33.50. The Score for UCO is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- UCO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $45.70. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UCO Stock Price Chart
What is ProShares Ultra Bloomberg Crude Oil's stock price today?
-
The ProShares Ultra Bloomberg Crude Oil share price today is $33.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UCO is experiencing slight selling pressure.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $45.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.
UCO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.62 | Buy |
Relative Strength Index (14 RSI): | 60.24 | Buy |
Chaikin Money Flow: | -221819 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.81 - 33.15) | Buy |
Bollinger Bands (100): | (29.62 - 33.64) | Buy |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.79 | Sell |
Relative Strength Index (14 RSI): | 38.41 | Sell |
Chaikin Money Flow: | 239305 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.72 - 49.1) | Sell |
Bollinger Bands (100): | (49.87 - 64.91) | Sell |
UCO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.32 | Buy |
20-day SMA: | 31.49 | Buy |
50-day SMA: | 31.84 | Buy |
200-day SMA: | 30.95 | Buy |
8-day EMA: | 33.1 | Buy |
20-day EMA: | 32.28 | Buy |
50-day EMA: | 31.89 | Buy |
200-day EMA: | 30.8 | Buy |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.61 | Buy |
20-day SMA: | 47.29 | Sell |
50-day SMA: | 51.65 | Sell |
200-day SMA: | 47.07 | Sell |
8-day EMA: | 45.93 | Sell |
20-day EMA: | 47.34 | Sell |
50-day EMA: | 50.89 | Sell |
200-day EMA: | 50 | Sell |
ProShares Ultra Bloomberg Crude Oil Earnings Growth & UCO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.
ProShares Ultra Bloomberg Crude Oil Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |